What is WellTrackONE?
WellTrackONE operates at the intersection of clinical efficiency and regulatory compliance, providing a specialized platform for Annual Wellness Visits (AWVs). By streamlining Health Risk Assessments and Chronic Care Management, the company enables healthcare providers and senior living facilities to optimize patient outcomes while navigating complex CMS requirements. The platform serves as a critical tool for MIPS and MACRA compliance, offering actionable clinical recommendations and risk adjustment coding that directly impact the financial health of medical practices. Through its data-driven approach, WellTrackONE effectively bridges the gap between administrative burden and high-quality patient care, positioning itself as an essential partner for providers aiming to improve operational performance in a value-based care environment.
How much funding has WellTrackONE raised?
WellTrackONE has raised a total of $5.3M across 5 funding rounds:
Private Equity
$891K
Series A
$1.5M
Private Equity
$1.9M
Private Equity
$774K
Debt
$187K
Private Equity (2014): $891K, investors not publicly disclosed
Series A (2015): $1.5M led by BioAdvance and Easton Capital Group
Private Equity (2016): $1.9M, investors not publicly disclosed
Private Equity (2017): $774K, investors not publicly disclosed
Debt (2021): $187K backed by PPP
Key Investors in WellTrackONE
BioAdvance
BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life.
Easton Capital Group
Easton Capital Investment Group manages approximately $200 million on behalf of institutional investors, focusing on strategic growth investments with a long-term perspective.
Undisclosed Investors
What's next for WellTrackONE?
With the recent influx of capital, WellTrackONE is well-positioned to accelerate its product development roadmap and deepen its market penetration. The company is expected to focus on enhancing its automated reporting capabilities and expanding its suite of clinical decision support tools. As the healthcare industry continues to shift toward value-based reimbursement models, WellTrackONE's ability to simplify compliance and improve patient engagement will likely serve as a primary driver for future growth. Strategic priorities will likely include scaling its sales force to reach a broader network of healthcare providers and potentially exploring new integrations with electronic health record systems to further embed its technology into the clinical workflow.
See full WellTrackONE company page
